Author | Mark Schroeder, MD | OncLive

Author | Mark Schroeder, MD


Dr. Schroeder on Tolerability of Treatment For Myeloma

October 25, 2018


Mark Schroeder, MD, assistant professor of medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine in St. Louis, Siteman Cancer Center, discusses the tolerability of treatment regimens for patients with relapsed/refractory myeloma.